| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |